• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性高草酸尿症 2 型患儿的临床特征、基因谱及短期预后:一项全国性经验。

Clinical characteristics, genetic profile and short-term outcomes of children with primary hyperoxaluria type 2: a nationwide experience.

机构信息

Pediatric Nephrology Services, Department of Pediatrics, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, 605006, India.

Department of Pediatric Nephrology, St John's Medical College Hospital, Bangalore, India.

出版信息

Pediatr Nephrol. 2024 Apr;39(4):1093-1104. doi: 10.1007/s00467-023-06200-9. Epub 2023 Nov 2.

DOI:10.1007/s00467-023-06200-9
PMID:37914965
Abstract

BACKGROUND

Three types of primary hyperoxaluria (PH) are recognized. However, data on PH type 2 (PH2), caused by defects in the GRHPR gene, are limited.

METHODS

We reviewed the medical records of patients < 18 years of age with genetically-proven PH2 from seven centres across India to identify the age of onset, patterns of clinical presentation, short-term outcomes and genetic profile, and to determine if genotype-phenotype correlation exists.

RESULTS

We report 20 patients (all with nephrolithiasis or nephrocalcinosis) diagnosed to have PH2 at a median (IQR) age of 21.5 (7, 60) months. Consanguinity and family history of kidney stones were elicited in nine (45%) and eight (40%) patients, respectively. The median (IQR) serum creatinine at PH2 diagnosis was 0.45 (0.29, 0.56) mg/dL with the corresponding estimated glomerular filtration rate being 83 (60, 96) mL/1.73 m/min. A mutational hotspot (c.494 G > A), rare in Caucasians, was identified in 12 (60%) patients. An intronic splice site variant (c.735-1G > A) was noted in five (25%) patients. Four (20%) patients required surgical intervention for stone removal. Major adverse kidney events (mortality or chronic kidney disease (CKD) stages 3-5) were noted in six (30%) patients at a median (IQR) follow-up of 12 (6, 27) months. Risk factors for CKD progression and genotype-phenotype correlation could not be established.

CONCLUSIONS

PH2 should no longer be considered an innocuous disease, but rather a potentially aggressive disease with early age of presentation, and possible rapid progression to CKD stages 3-5 in childhood in some patients. A mutational hotspot (c.494 G > A variant) was identified in 60% of cases, but needs further exploration to decipher the genotype-phenotype correlation.

摘要

背景

原发性高草酸尿症(PH)有三种类型。然而,关于由 GRHPR 基因突变引起的 PH2 的数据有限。

方法

我们回顾了来自印度七个中心的年龄<18 岁的经基因证实的 PH2 患者的病历,以确定发病年龄、临床表现模式、短期结果和遗传特征,并确定是否存在基因型-表型相关性。

结果

我们报告了 20 名患者(均患有肾结石或肾钙质沉着症),在中位数(IQR)年龄 21.5(7,60)个月时被诊断为 PH2。在 9 名(45%)和 8 名(40%)患者中分别发现了近亲结婚和肾结石家族史。在 PH2 诊断时,中位数(IQR)血清肌酐为 0.45(0.29,0.56)mg/dL,相应的估计肾小球滤过率为 83(60,96)mL/1.73 m/min。在 12 名(60%)患者中发现了一个突变热点(c.494 G > A),在白种人中罕见。在 5 名(25%)患者中发现了一个内含子剪接位点变异(c.735-1G > A)。有 4 名(20%)患者需要手术取石。在中位数(IQR)随访 12(6,27)个月时,有 6 名(30%)患者发生主要不良肾脏事件(死亡或慢性肾脏病(CKD)3-5 期)。CKD 进展的危险因素和基因型-表型相关性无法确定。

结论

PH2 不应再被视为一种无害的疾病,而应被视为一种潜在的侵袭性疾病,在某些患者中,其发病年龄较早,且可能在儿童期迅速进展至 CKD 3-5 期。在 60%的病例中发现了一个突变热点(c.494 G > A 变异),但需要进一步探索以阐明基因型-表型相关性。

相似文献

1
Clinical characteristics, genetic profile and short-term outcomes of children with primary hyperoxaluria type 2: a nationwide experience.原发性高草酸尿症 2 型患儿的临床特征、基因谱及短期预后:一项全国性经验。
Pediatr Nephrol. 2024 Apr;39(4):1093-1104. doi: 10.1007/s00467-023-06200-9. Epub 2023 Nov 2.
2
Clinical characterization of primary hyperoxaluria type 3 in comparison with types 1 and 2.原发性高草酸尿症 3 型与 1 型和 2 型的临床特征比较。
Nephrol Dial Transplant. 2022 Apr 25;37(5):869-875. doi: 10.1093/ndt/gfab027.
3
[Clinical analysis of seven cases with primary hyperoxaluria type 1 in children].7例儿童1型原发性高草酸尿症临床分析
Zhonghua Er Ke Za Zhi. 2020 Feb 2;58(2):129-134. doi: 10.3760/cma.j.issn.0578-1310.2020.02.012.
4
Comprehensive evaluation of patients with primary hyperoxaluria type 1: A nationwide study.原发性高草酸尿症 1 型患者的综合评估:一项全国性研究。
Nephrology (Carlton). 2024 Apr;29(4):201-213. doi: 10.1111/nep.14273. Epub 2024 Jan 30.
5
Primary hyperoxaluria type 2 in children.儿童2型原发性高草酸尿症
Pediatr Nephrol. 2002 Aug;17(8):597-601. doi: 10.1007/s00467-002-0858-6. Epub 2002 Jun 6.
6
Clinical spectrum of primary hyperoxaluria type 1: Experience of a tertiary center.1型原发性高草酸尿症的临床谱:一家三级中心的经验
Nephrol Ther. 2017 May;13(3):176-182. doi: 10.1016/j.nephro.2016.08.002. Epub 2017 Feb 1.
7
Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-up.2 型原发性高草酸尿症患者有显著的发病率,需要密切随访。
Kidney Int. 2019 Dec;96(6):1389-1399. doi: 10.1016/j.kint.2019.08.018. Epub 2019 Sep 3.
8
Nine novel HOGA1 gene mutations identified in primary hyperoxaluria type 3 and distinct clinical and biochemical characteristics in Chinese children.在中国儿童中发现的 3 型原发性高草酸尿症中 9 种新型 HOGA1 基因突变及不同的临床和生化特征。
Pediatr Nephrol. 2019 Oct;34(10):1785-1790. doi: 10.1007/s00467-019-04279-7. Epub 2019 May 23.
9
Updated genetic testing of Italian patients referred with a clinical diagnosis of primary hyperoxaluria.对临床诊断为原发性高草酸尿症的意大利患者进行的基因检测更新。
J Nephrol. 2017 Apr;30(2):219-225. doi: 10.1007/s40620-016-0287-4. Epub 2016 Mar 5.
10
Identification of 8 novel gene variants in primary hyperoxaluria in 21 Chinese children with urinary stones.鉴定 21 例尿路结石的原发性高草酸尿症患儿中的 8 种新基因变异。
World J Urol. 2019 Aug;37(8):1713-1721. doi: 10.1007/s00345-018-2563-5. Epub 2018 Nov 28.

引用本文的文献

1
The efficacy and safety of RNA interference for the treatment of primary hyperoxaluria: a systematic review and meta-analysis.RNA干扰治疗原发性高草酸尿症的疗效和安全性:系统评价与荟萃分析。
Clin Kidney J. 2024 Nov 29;18(4):sfae383. doi: 10.1093/ckj/sfae383. eCollection 2025 Apr.
2
Global access to management of primary hyperoxaluria: a survey on behalf of OxalEurope, G&K Working Group of the ERA and ESPN.全球原发性高草酸尿症管理的可及性:代表OxalEurope、欧洲罕见病研究协会G&K工作组和欧洲小儿肾脏病学会进行的一项调查
Nephrol Dial Transplant. 2025 Aug 29;40(9):1688-1697. doi: 10.1093/ndt/gfaf035.
3
Synthesis and LDHA Inhibitory Activity of New Stiripentol-Related Compounds of Potential Use in Primary Hyperoxaluria.

本文引用的文献

1
Four novel variants identified in primary hyperoxaluria and genotypic and phenotypic analysis in 21 Chinese patients.在原发性高草酸尿症中鉴定出的四种新变异及21例中国患者的基因型和表型分析
Front Genet. 2023 Apr 17;14:1124745. doi: 10.3389/fgene.2023.1124745. eCollection 2023.
2
Homozygous GRHPR C.494G>A mutation is deleterious that causes early onset of nephrolithiasis in West Bengal, India.纯合子GRHPR基因C.494G>A突变具有有害性,会导致印度西孟加拉邦的肾结石早期发病。
Front Mol Biosci. 2022 Dec 22;9:1049620. doi: 10.3389/fmolb.2022.1049620. eCollection 2022.
3
Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope.
用于原发性高草酸尿症的新型司替戊醇相关化合物的合成及乳酸脱氢酶A抑制活性
Int J Mol Sci. 2024 Dec 10;25(24):13266. doi: 10.3390/ijms252413266.
4
Second transplantation after kidney graft loss in primary hyperoxaluria type 2: a pedigree study and mutation analysis.2 型原发性高草酸尿症肾移植失功后的二次移植:家系研究与突变分析。
Ren Fail. 2024 Dec;46(2):2417743. doi: 10.1080/0886022X.2024.2417743. Epub 2024 Oct 24.
5
Mutation Characteristics of Primary Hyperoxaluria in the Chinese Population and Current International Diagnosis and Treatment Status.中国人群原发性高草酸尿症的突变特征及当前国际诊断与治疗现状
Kidney Dis (Basel). 2024 Jun 17;10(4):313-326. doi: 10.1159/000539516. eCollection 2024 Aug.
6
A molecular journey on the pathogenesis of primary hyperoxaluria.原发性高草酸尿症发病机制的分子之旅。
Curr Opin Nephrol Hypertens. 2024 Jul 1;33(4):398-404. doi: 10.1097/MNH.0000000000000987. Epub 2024 Apr 11.
原发性高草酸尿症临床实践建议:来自欧洲罕见肾脏病网络(ERKNet)和欧洲草酸尿症协会(OxalEurope)的专家共识声明
Nat Rev Nephrol. 2023 Mar;19(3):194-211. doi: 10.1038/s41581-022-00661-1. Epub 2023 Jan 5.
4
Clinical and molecular characterization of a large primary hyperoxaluria cohort from Saudi Arabia: a retrospective study.沙特阿拉伯大原发性高草酸尿症队列的临床和分子特征:一项回顾性研究。
Pediatr Nephrol. 2023 Jun;38(6):1801-1810. doi: 10.1007/s00467-022-05784-y. Epub 2022 Nov 21.
5
The retinal phenotype in primary hyperoxaluria type 2 and 3.原发性高草酸尿症 2 型和 3 型的视网膜表型。
Pediatr Nephrol. 2023 May;38(5):1485-1490. doi: 10.1007/s00467-022-05765-1. Epub 2022 Oct 19.
6
Genetic assessment in primary hyperoxaluria: why it matters.原发性高草酸尿症的遗传评估:为何重要。
Pediatr Nephrol. 2023 Mar;38(3):625-634. doi: 10.1007/s00467-022-05613-2. Epub 2022 Jun 13.
7
European Association of Urology and European Society for Paediatric Urology Guidelines on Paediatric Urinary Stone Disease.欧洲泌尿外科学会和欧洲小儿泌尿外科学会儿童尿石病指南。
Eur Urol Focus. 2022 May;8(3):833-839. doi: 10.1016/j.euf.2021.05.006. Epub 2021 May 26.
8
Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-up.2 型原发性高草酸尿症患者有显著的发病率,需要密切随访。
Kidney Int. 2019 Dec;96(6):1389-1399. doi: 10.1016/j.kint.2019.08.018. Epub 2019 Sep 3.
9
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents.临床实践指南:儿童和青少年高血压的筛查和管理。
Pediatrics. 2017 Sep;140(3). doi: 10.1542/peds.2017-1904. Epub 2017 Aug 21.
10
Primary hyperoxaluria in populations of Pakistan origin: results from a literature review and two major registries.巴基斯坦裔人群中的原发性高草酸尿症:文献回顾和两个主要登记处的结果。
Urolithiasis. 2018 Apr;46(2):187-195. doi: 10.1007/s00240-017-0996-8. Epub 2017 Jun 28.